Novo Nordisk A/S (CPSE:NOVO B) agreed to acquire a 64.4% stake in Biocorp Production (ENXTPA:ALCOR) for 99.1 million on June 19, 2023. Under the terms, 35 per share in cash will be paid. Acquisition is subject to subject to customary regulatory approvals.
1st Jan change | Capi. | |
---|---|---|
+8.33% | 217B | |
+6.72% | 183B | |
+10.18% | 131B | |
+24.91% | 106B | |
-0.95% | 62.16B | |
+10.56% | 51.02B | |
+4.81% | 50.89B | |
-0.24% | 40.16B | |
+1.22% | 34.79B |